A clinical and pharmacological study of arsenic trioxide in advanced multiple myeloma patients.
Rousselot P, Larghero J, Arnulf B, Poupon J, Royer B, Tibi A, Madelaine-Chambrin I, Cimerman P, Chevret S, Hermine O, Dombret H, Claude Brouet J, Paul Fermand J.
Rousselot P, et al. Among authors: arnulf b.
Leukemia. 2004 Sep;18(9):1518-21. doi: 10.1038/sj.leu.2403424.
Leukemia. 2004.
PMID: 15269785